F

Firebrick Pharma Ltd
ASX:FRE

Watchlist Manager
Firebrick Pharma Ltd
ASX:FRE
Watchlist
Price: 0.065 AUD
Market Cap: 16.4m AUD

Operating Margin
Firebrick Pharma Ltd

-976.7%
Current
-201 827.2%
Average
5.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-976.7%
=
Operating Profit
-2.9m
/
Revenue
293.4k

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
AU
Firebrick Pharma Ltd
ASX:FRE
16.4m AUD
-977%
US
Eli Lilly and Co
NYSE:LLY
1T USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
511.7B USD
27%
CH
Roche Holding AG
SIX:ROG
269.5B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
216.3B GBP
24%
CH
Novartis AG
SIX:NOVN
216.4B CHF
33%
US
Merck & Co Inc
NYSE:MRK
270.2B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
42%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
11%
US
Pfizer Inc
NYSE:PFE
142.4B USD
29%
No Stocks Found

Firebrick Pharma Ltd
Glance View

Market Cap
16.4m AUD
Industry
Pharmaceuticals

Firebrick Pharma Ltd. engages in the development and manufacture of pharmaceutical products. The company is headquartered in Melbourne, Victoria. The company went IPO on 2022-01-28. The firm is focused to develop Nasodine, a nasal spray that contains the broad spectrum antimicrobial agent called povidone-iodine. The firm is engaged in product formulation, packaging and manufacturing development. Nasodine nasal spray medicine targets the cause of colds, where they start in the nose. Its nasal spray is responsible for respiratory infections, such as the common cold. The firm's Series C funding, Phase III trial has been completed.

FRE Intrinsic Value
0.008 AUD
Overvaluation 87%
Intrinsic Value
Price
F
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-976.7%
=
Operating Profit
-2.9m
/
Revenue
293.4k
What is the Operating Margin of Firebrick Pharma Ltd?

Based on Firebrick Pharma Ltd's most recent financial statements, the company has Operating Margin of -976.7%.

Back to Top